digital currency data People searches

Japanese Reuters's short-term non-manufacturing boom judgment index in December is 30, with the previous value of 19; Reuters's short-term judgment index of manufacturing prosperity in December was -1, with the previous value of 5.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Senior US official: Russia has provided important assistance to Iran in fighter planes, missile defense and space technology.

Wells Fargo: Reduce the target price of Dow Chemical from $60 to $55, and maintain the "overweight" rating.Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine. According to the Tass news agency, Russian President Vladimir Putin and Hungarian Prime Minister Orban discussed the further development of energy projects.Liaoning Energy: Guo Hongbo, the chairman of the board of directors, resigned due to job change. Liaoning Energy (600758) announced on the evening of December 11th that Guo Hongbo applied to resign as the chairman, director and all the special committees under the board of directors due to job change. After resigning, Guo Hongbo no longer holds any position in the company.

Morgan Asset Management: In 2025, there are sufficient reasons to continue to over-allocate US stocks. Sylvia Sheng, global multi-asset strategist of Morgan Asset Management, said that there are sufficient reasons to continue to over-allocate US stocks and increase exposure to small and medium-sized stocks. She pointed out that although the valuation may look high, it is expected that the profit growth of S&P 500 companies will continue. Sheng wrote that it is estimated that in 2025, the contribution of the six giants in the S&P 500 index to the profit growth of the other 494 stocks will be the same, and the profit growth of these six giants is expected to slow down from 40% in 2024 to 22%. In the international market, Morgan Asset Management continues to over-allocate Japanese stocks, and its quantitative model shows that the yield of Japanese stocks is attractive and the bottom-up profitability is strong.Huadian energy: The subordinate power plants and holding companies received government subsidies of 22.33 million yuan. huadian energy announced that the subordinate power plants and holding companies of the company received government subsidies related to income of 22.33 million yuan on December 9, 2024. Among them, Harbin No.3 Power Plant of huadian energy Co., Ltd. received a government subsidy of 10.87 million yuan, and Harbin Thermal Power Co., Ltd. received a government subsidy of 11.46 million yuan. In accordance with the relevant provisions of Accounting Standards for Business Enterprises No.16-Government Subsidies, the company included this subsidy in the current profit and loss, and it is estimated that the total profit of the company in 2024 will be increased by 8.39 million yuan.Bank of America: Resume the coverage of Lilly and give it a "buy" rating with a target price of $997.